Good work 202020; Quote: Biota also has something that they call FluNet," Hayden added. This drug is a longer-acting version of Relenza, known generically as zanamivir. The National Institute of Allergy and Infectious Diseases has given Biota $2.4 million, with a promise of up to $8.5 million, to develop this one?
Do anyone know whether this was the funding that was announced on 30 Sept 04 or is it a new one: 30/09/2004: Awarded US Gov Funding for New Influenza Drug
Wasn’t flu-net abandoned or terminated?
BTA Price at posting:
$2.93 Sentiment: Buy Disclosure: Held